‹ All Posts
Rakesh Kumar Singhal

9 mins ago · SEBI Registration INH100003282

NARAYANA HRUDAYALAYA Results Analysis-Q2FY2027

NH Financial performance and key operating metrics (Consolidated) : Operating Revenue for Q2FY27 is Rs. 2,844 Crs., 73.01% growth YoY, Total Income is Rs. 2,896 Crs., 73.62% growth YoY, EBITDA is Rs. 605 Crs., 41.95% growth YoY, But EBITDA Margin is 20.91% declined by 466 Basis points YoY, PBT Rs. 343 Crs. 16.2% growth YoY, PAT Rs.301 Crs. 16.59% growth YoY. On QoQ basis Op. Revenue is up by 5.98%, Total Income is up by 6.49%, EBITDA is up by 19.84%, PBT is up by 31.86% PAT is also up by 45.29%. Volume growth: IP volumes +4% YoY; OP footfall +12.5% YoY, Occupied bed days +6%; ARPP: INR 1.63 lakh (+9.4% YoY). International patients in India: 6–7% of hospital revenue. UK cash conversion is strong: NHS “pays on time and partially in advance.” The drag is India + Cayman collections, including government payers and some insurance payers; Q2 usually strong but was slower this time. No near-term India bed addition; Total Operational Beds 6,119, longer-term additions flagged, but no quarterly phasing.

#WatchOutFor#MacroViews#EquityResearch#TrendingSectors#FundamentalViews
510 likes·102 comments